FDA Inspection 1264281 — Carter BloodCare - Irving
The FDA completed an inspection of Carter BloodCare - Irving on Mar 13, 2025 in Irving, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 13, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Irving, TX (United States)